Science Connections > Wilsede Science Connections
 

Forthcoming Issues

EBMT Hamburg • Germany • March 19–22 • 2006

Congress President: N. Schmitz, Hamburg

Scientific Chair: A. Zander, Hamburg

The history and the future of stem cell transplantation

  • From mice to man D. van Bekkum (Rijswijk, NL)
  • Sleepless in Seattle - milestones of a successful experimental and clinical programme R. Storb (Seattle, USA)
  • The future, J.F. Apperley (London, UK)

Tolerance: a double - edged sword

  • How tumours escape T. Boon (Brussels, B
  • Transplantation tolerance P. Matzinger (Bethesda, USA)

The basics of transplant immunology

  • Innate immunity S. Strober (Stanford, USA)
  • Adaptive immunity H. Stauss (London, UK)

London, 25.May, 2005. Anniversary Celebration Meeting

Chair: Professor Melvin Greaves

  • Tracking through the jungles of genomes Dr. Leanne Wiedemann Stowers Institute for Medical Research Kansas City
  • Did we discover Buddha genes? Professor Shuki Mizutani Tokyo Medical Dental University
  • Beyond Berkeleyomics: is there a message in the sequence? Dr. Joe Wiemels University of California San Francisco
  • The sexiest cells in the universe? Professor Tariq Enver Weatherall Institute of Molecular Medicine, Oxford
  • Removing the blindfold from the marksman: Using tools of theretiarii gladiators Professor John Kersey University of Minnesota, Minneapolis
  • Leukemias as “models” for epithelial cancers: It’s all about stem cells and chromosomes! Professor Carios Caldas University of Cambridge
  • Tea leaves and tails from Hong Kong Professor Lichan University of Hong Kong
  • Cancer stem cells: How the Mounties got their man Professor John Dick Princess Margasret Hospital, Toronto
  • Me, industrial science, target treatmemt And why Mel is not always right Professor Gareth Morgan Institute of Cancer Research, Sutton
  • Life beyond the ICR Dr. Ana Terese Maia University of Cambridge
  • Epilogue Professor Mel Greaves Institute of Cancer Research, London

Wilsede, June 18-22, XVI. Wilsede Meeting

Organisation: Professeor Zander, Dr. Carol Stocking, Dr.Boris Fehse

  • B-Cell Development Fritz Melschers Biozentrum of the University of Basel
  • Sixty years of immunology Nicholas Mitchison Windeyer Institute of Medical Science, London
  • Supressor T cells: answered and unanswerd questions Harald von Boehmer Dana-Farber Cancer Institute, Boston
  • Tumor stroma: The Achilles heel of the tumor Thomas Blankenstein Max-Delbrück-Centrum für Molekulare Medizin,Berlin
  • Functional analysis of TCR-transduced MHCclass I-restricted helper T-cells and their role in tumor protection Hans Stauss University College London

Interviews

  • Professor Peter Chumakow Russian Academy of Sciences, Moscow
  • Professor Elena I.Frolova Russian Academy of Sciences, Moscow
  • Professor Amanda Fisher ICSM Hammersmith Hospital, London
  • Professor Hans-Jochen Kolb Universität München
  • Professor Katarina Le Blank Karolinska University Hospital, Stockholm
  • Professor Frank Marini III M.D. Anderson Cancer Center, Houston
  • Professor Fritz Melchers Biozentrum of the University of Basel
  • Professor Vladimir Prassolov Russian Academy of Science, Moscow
  • ProfessorYair Reissner Weizmann Institute of Science, Israel
  • Alexandra Sipol Pavlov`s State Medical University, Saint-Petersburg
  • Professor Hans Stauss University College London

XXII IACRLRD Symposion, 2.-5. July, 2005, Heidelberg

Organisation: Professor Rüdiger Hehlmann

  • The still open questions of differentiation and self-renewal of stem-cells Don Metcalf Melbourne
  • Nuclear cloning, embryonic stem cells and The promise for transplantation therapy Rudi Jaenisch Boston
  • From CML to targeted therapy in solid cancers Rüdiger Hehlmann Mannheim
  • CML present and future H. Kantarjian Houston
  • Modern Trends in genetics of lymphomas Carlo Croce, Columbus (nur Interview)
  • Progress in curing adult acute leukemias Clara Bloomfield, Columbus
  • Human endogenous retroviruses including Introduction to retroviruses Reinhart Kurt
  • T-Lymphocyte transformation by oncogenic Herpesvirus including HHV 6 and 8 B.Fleckenstein, Erlangen
  • What’s up in HIV vaccines-any implications to cancer? Robert Gallo, Baltimore

Interviews

  • Professor Rüdiger Hehlmann, Mannheim
  • Professor Carlo Croce, Columbus
  • Professor Jams C. Neil, Glasgow
  • Professor Peter Bieberfeld, Stockholm
  • Professor Ruth Ruprecht, Bosten
  • Professor Valery Savchenko, Moscow
  • Professor Jan Svoboda, Prag